ADVANCED MALIGNANCIES
Clinical trials for ADVANCED MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new ADVANCED MALIGNANCIES trials appear
Sign up with your email to follow new studies for ADVANCED MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Immune-Boosting drug tested in advanced cancer patients
Disease control OngoingThis study is testing a new immunotherapy drug called PF-06801591 in adults with advanced cancers that have spread or returned after standard treatments. The goal is to find a safe dose and see if the drug can help shrink tumors, particularly in non-small cell lung cancer. Partic…
Matched conditions: ADVANCED MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated Apr 04, 2026 00:04 UTC
-
Cancer patients continue experimental drug treatment in Long-Term safety study
Disease control OngoingThis study follows cancer patients who were already receiving experimental drugs in previous trials. Researchers want to understand the long-term safety of these cancer treatments, including how well patients tolerate them over extended periods. The study includes patients with v…
Matched conditions: ADVANCED MALIGNANCIES
Phase: PHASE3 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
New cancer drug AB598 enters first human trials
Disease control OngoingThis is the first human study testing the safety of an experimental drug called AB598 in people with advanced cancers. The trial will enroll 40 participants with various cancers including lung, stomach, bladder, and breast cancer to determine safe dosage levels and monitor side e…
Matched conditions: ADVANCED MALIGNANCIES
Phase: PHASE1 • Sponsor: Arcus Biosciences, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New Immune-Boosting drugs tested in fight against advanced lung cancer
Disease control OngoingThis early-stage study is testing the safety and how the body processes two immunotherapy drugs, cemiplimab and fianlimab, in Japanese patients with advanced lung cancer. The goal is to see if these drugs, alone or combined with chemotherapy, can help the patient's own immune sys…
Matched conditions: ADVANCED MALIGNANCIES
Phase: PHASE1 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC